Scorpius Holdings, Inc. SCPX
At closeNov 3, 2026, 4:00 PM EST
After hours · Nov 3, 4:00 PM ET
- YTD
- +200.00%
- 1 year
- -50.00%
- Market cap
- 36.69K
- Revenue (ttm)
- 9.85M
- EPS (ttm)
- -4.18
- Shares out
- 4.33M
- Forward P/E
- -0.11
- YTD return
- +200.00%
- 1-year return
- -50.00%
- Volume
- 60.81K
- Avg volume
- 8.79K
- Open
- 0.01
- Previous close
- 0.0006
- Day's range
- 0.01 – 0.0111
- 52-week range
- 0.0001 – 0.10
- Beta
- -0.33
- Price target
- 5.00 (+833233.3%)
YTD +0.0004 (+200.00%)
Key statistics
- Enterprise value
- 12.72M
- PEG ratio
- 0.00
- Price / sales
- 0.14
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 15.50%
- Free cash flow
- -16.05M
- Total cash
- 1.51M
- Total debt
- 15.87M
- Return on equity
- -91.85%
- Short % of float
- 3.22%
- 50-day average
- 0.6294
- 200-day average
- 0.57885
Analyst view
- Strong buy0
- Buy1
- Hold0
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 1, 2023 | Brookline Capital | down | Buy | Hold |
| Apr 3, 2023 | Maxim Group | down | Buy | Hold |
| Mar 3, 2021 | Cantor Fitzgerald | init | — | Overweight |
About Scorpius Holdings, Inc.
Scorpius Holdings, Inc., through its subsidiary Scorpius BioManufacturing, operates as an integrated contract development and manufacturing organization. The company engages in clinical and commercial drug substance manufacturing; and release and stability testing activities. It is also involved in the provision of various process development services, including upstream and downstream development and optimization, and analytical method development solutions, as well as cell line development, testing, and characterization services. The company was formerly known as NightHawk Biosciences, Inc. and changed its name to Scorpius Holdings, Inc. in February 2024. Scorpius Holdings, Inc. was incorporated in 2008 and is based in Morrisville, North Carolina.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- scorpiusbiologics.com
News
Crude Oil Gains 3%; 3M Posts Better-Than-Expected Q1 Results 
12 Health Care Stocks Moving In Monday's Intraday Session 
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - 12 Health Care Stocks Moving In Friday's Pre-Market Session
Nasdaq Surges Over 300 Points; State Street Earnings Top Views 
S&P 500 Gains 1%; Fastenal Posts Downbeat Earnings 
Dow Jumps Over 300 Points; US Industrial Production Beats Estimates 
12 Health Care Stocks Moving In Monday's Pre-Market Session 
12 Health Care Stocks Moving In Friday's Pre-Market Session 
Why Fortinet Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
Your note
Sign in to keep a note on SCPX — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| WOLF JEFFREY ALAN J.D. | Chief Executive Officer | Stock Award(Grant) | May 15, 2024 | 3,594,040 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Sabby Management, LLC | 1.36% | 346,256 | 107.48K | Sep 29, 2024 |
| Warberg Asset Management LLC | 0.37% | 95,000 | 29.49K | Sep 29, 2024 |
| Altium Capital Management, LP | 0.35% | 88,291 | 27.41K | Sep 29, 2024 |
| HRT Financial LP | 0.20% | 51,601 | 16.02K | Sep 29, 2024 |
| UBS Group AG | 0.08% | 19,290 | 5.99K | Sep 29, 2024 |
| Geode Capital Management, LLC | 0.06% | 15,904 | 4.94K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 0.06% | 15,605 | 4.84K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.01% | 3,451 | 1.07K | Oct 30, 2024 |